Joel Michalek

3PUBLICATIONS
26CO-AUTHORS
Haematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 24, 2023
Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma.

William Kelly, Adolfo Enrique Diaz Duque, Joel Michalek

|Jul 07, 2022
Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor Models.

Fuyang Li, Kathryn M Bondra, Samson Ghilu

|Nov 22, 2018
The HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma.

Narendra Bharathy, Noah E Berlow, Eric Wang

Pageof 1